Experimental Vaccine May Prevent Tuberculosis, Research Indicates.

Reuters (9/25, Hirschler) reports researchers found that an experimental vaccine from GlaxoSmithKline may prevent tuberculosis from developing in as many as half of those that receive it. The 54 percent efficacy rate achieved during a mid-stage clinical...